NEO earnings date and last-quarter result: last quarter beat, P/E -3.65. Updated 2026-07-23.
NeoGenomics (NEO) Research Hub
NeoGenomics (NEO) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 16.69 USD (+0.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.65, market cap 0.36B. This hub links to the full technical, earnings and options research available for NEO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 16.69 USD (+0.60%) |
| 52-week range | 10.26 USD – 20.15 USD |
| Trend regime | Range |
| 14-day RSI | 52 (Neutral) |
| Trailing P/E | -3.65 |
| Market cap | 0.36B |
| Dividend yield | 0.00% |
Available research for NEO
Covered Call on NEO: how it works, illustrative setup around the real 16.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NEO: how it works, illustrative setup around the real 16.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NEO: how it works, illustrative setup around the real 16.69 USD price, max profit/loss, breakeven and when to use it. Educational.
NEO technical analysis: range, last 16.69 USD, RSI 52, 52w range 10.26 USD–20.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NEO in?
NeoGenomics (NEO) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is NEO in an uptrend or downtrend?
As of 2026-10-26, NEO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NEO's trailing P/E ratio?
NEO's trailing P/E is -3.65, with a market cap of 0.36B. See the earnings research page for full valuation detail.